|
0
|
|
Cell therapy for brain tumors: The first 60 years.
(linkinghub.elsevier.com)
|
Mehta S
…
Gottschalk S
Cell Reports Medicine
2026-02-17
|
#cancer
#clinical trial
#immunotherapy
#car-t
|
|
0
|
|
CAR-T cells with the CD38(-)CD73(-)Tim-3(-)HLA-DR(+) phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL.
(linkinghub.elsevier.com)
|
Mikami T
…
Takita J
Cell Reports Medicine
2026-02-17
|
#metabolism
#immunotherapy
#car-t
#phenotype
#leukemia
|
|
0
|
|
Efficacy and safety of autologous CD5-KO anti-CD5 CAR-T cells in relapsed/refractory CD5(+) hematological malignancies.
(linkinghub.elsevier.com)
|
Cheng J
…
Zhu X
Cell Reports Medicine
2026-02-17
|
#immunotherapy
#car-t
#toxicity
#genome editing
#hematologic malignancy
|
|
0
|
|
Engineering chimeric antigen receptor CD4 T cells for Alzheimer's disease.
(pnas.org)
|
Boskovic P
…
Kipnis J
PNAS
2026-02-17
|
#inflammation
#immunotherapy
#car-t
#engineering
#neurodegeneration
|
|
0
|
|
Programmable iPSC-derived CAR-NK vesicles remodel the immune microenvironment and eradicate tumors.
(linkinghub.elsevier.com)
|
Zhang H
…
Xia P
Cell Reports Medicine
2026-02-17
|
#cancer
#immunotherapy
#car-t
#extracellular vesicles
#tumor microenvironment
|